Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-02-06
2010-11-30
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S090000, C544S105000
Reexamination Certificate
active
07842688
ABSTRACT:
Novel substituted piperidines of the general formulae (I) and (II)with the substituent definitions as explained in detail in the description are described. The compounds are suitable in particular as renin inhibitors and are highly potent.
REFERENCES:
patent: 6051712 (2000-04-01), Binggeli et al.
patent: 6150526 (2000-11-01), Binggeli et al.
patent: 6197959 (2001-03-01), Breu et al.
patent: 6376672 (2002-04-01), Breu et al.
patent: 2002/0087002 (2002-07-01), Breu et al.
patent: 2004/0204455 (2004-10-01), Cody et al.
patent: 97/09311 (1997-03-01), None
patent: 00/64873 (2000-11-01), None
patent: 00/64887 (2000-11-01), None
patent: 2004/002466 (2004-01-01), None
patent: 2004/089903 (2004-10-01), None
International Search Report issued on Mar. 1, 2005 in the International (PCT) Application PCT/EP2004/052389, on which the parent application of the present divisional application is based.
Eric Vieira et al., “Substituted Piperidines—Highly Potent Renin Inhibitors Due to Induced Fit Adaptation of the Active Site”, Bioorganic & Medicinal Chemistry Letters, vol. 9, pp. 1397-1402, XP002317176, 1999.
Rolf Güller et al., “Piperidine-Renin Inhibitors Compounds with Improved Physicochemical Properties”, Bioorganic & Medicinal Chemistry Letters, ISSN: 0960-894X, vol. 9, No. 10, pp. 1403-1408, XP002317171, 1999.
H.P. Märki et al., “Piperidine renin inhibitors: from leads to drug candidates”, Farmaco, 56(1-2) ISSN: 0014-827X, pp. 21-27, XP002317172, 2001.
Daiga M. Helmeste et al., “Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets”, European Journal of Pharmacology, vol. 288, pp. 373-377, XP002317173, 1995.
Matthew G. Bursavich et al., “From Peptides to Non-Peptide Peptidomimetics: Design and Synthesis of New Piperidine Inhibitors of Aspartic Peptidases”, Organic Letters, vol. 3, No. 15, pp. 2317-2320, XP002317174, 2001.
Matthew G. Bursavich et al., “Solid-Phase Synthesis of Aspartic Peptidase Inhibitors: 3-Alkoxy-4-Aryl Piperidines”, Organic Letters, vol. 3, No. 17, pp. 2625-2628, XP002317175, 2001.
Herold Peter
Jotterand Nathalie
Mah Robert
Stojanovic Aleksandar
Stutz Stefan
Habte Kahsay T
Novartis Pharma AG
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Organic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Organic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Organic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4243394